|
J Biol Chem, Vol. 273, Issue 27, 17206-17215, July 3, 1998
Regulation of Expression within a Gene Family
THE CASE OF THE RAT B- AND D-CRYSTALLIN PROMOTERS*
Erik Jan
Klok,
Siebe T.
van Genesen,
Azem
Civil,
John G. G.
Schoenmakers , and
Nicolette H.
Lubsen
From the Department of Molecular Biology, University of Nijmegen,
Toernooiveld 1, 6525 ED Nijmegen, The Netherlands
 |
ABSTRACT |
The six closely related and clustered rat
-crystallin genes, the A- to F-crystallin genes, are
simultaneously activated in the embryonic lens but differentially shut
down during postnatal development with the B-crystallin gene, the
last one to be active. We show here that developmental silencing of the
D-crystallin promoter correlates with delayed demethylation during
lens fiber cell differentiation. Methylation silencing of the
D-crystallin promoter is a general effect and does not require the
methylation of a specific CpG, nor does methylation interfere with
factor binding to the proximal activator. In later development, the
D-crystallin promoter is also shut down earlier by a repressor that
footprints to the 91/ 78 region. A factor with identical properties
is present in brain. Hence, a ubiquitous factor has been recruited as a
developmental regulator by the lens. All -crystallin promoters
tested contain upstream silencers, but at least the B-crystallin
silencer is distinct from the D-crystallin silencer. The
-crystallin promoters were found to share a proximal activator (the
-box; around 50), which behaves as a MARE. The B-box is
recognized with much lower avidity than the D-box. By swapping
elements between the B- and the D-crystallin promoter, we show
that activation by the B-box requires a directly adjacent 46/ 38
AP-1 consensus site. These experiments also uncovered another positive
element in the D-crystallin promoter, around 10. In the context of
the D-crystallin promoter, this element is redundant; in the context
of the B-crystallin promoter, it can replace the 46/ 38
element.
 |
INTRODUCTION |
The mammalian genome contains a large number of gene families,
which encode related proteins with similar structure and function, yet
are optimized for a particular developmental and differentiation stage.
The pattern of expression of gene family members varies between
families. For example, in the -globin gene family, the paradigm of a
clustered gene family, expression switches between members such that
only one or two genes are active at the same time (for review, see Ref.
1). In contrast, the six clustered and closely related members of the
-crystallin gene family (the A- to F-crystallin genes), which
encode abundant structural proteins of the vertebrate lens, are all
simultaneously active in the embryonic lens but switched off
individually during postnatal development (2-5). In the rat, at 3 months of age the B-crystallin mRNA is still present at 90% of
the level at birth, whereas the transcript level from the
D-crystallin gene has dropped to 60%, and those of the E- and
F-crystallin genes have dropped to 5% of the level at birth (4). As
lens cells do not die and as the younger lens cells overlay the older
cells, the consequence of this pattern of gene expression is the
creation of a -crystallin gradient across the eye lens, which
correlates inversely with the water gradient. This gradient in turn
sets the gradient of refraction across the lens and thereby prevents
optical aberration.
The mechanism of the developmental regulation of the -crystallin
gene expression is not known. There is a strong negative correlation
between the methylation state of a -crystallin gene promoter region
and gene activity, suggesting that DNA methylation, or rather lack of
DNA demethylation, is involved in silencing the genes (6). Differential
expression or availability of transactivating factors is also likely to
be causally involved in developmental regulation of expression. It is
generally assumed that the closely related A-F-crystallin genes
share a common regulatory element that specifies the lens specificity
of these genes. The prime candidate for such an element is the
palindromic sequence (here denoted the -box) located upstream of the
TATA box (Fig. 1). Mutations of this sequence abolish promoter activity
in transfection studies (7, 11, 12). Furthermore, Goring et
al. (13) have shown that a pentamer of the mouse F-crystallin
-box sequence directs lens-specific expression in transgenic mice.
The expression of this construct, however, was restricted to the
embryonic lens nucleus, and it was suggested that the wider range of
developmental expression of the mouse F-crystallin promoter is
determined by upstream enhancers (13, 14).
The study of the regulatory mechanisms of crystallin gene expression is
complicated by the peculiar mode of growth of the lens; the lens
epithelial cells differentiate to lens fiber cells at the equator of
the lens. The fiber cells of a late developmental stage but at an early
differentiation state thus overlay fiber cells of an earlier
developmental stage but at a later differentiation state. The lens is
thus a mixture of cells at different developmental and differentiation
stages. To obtain a fiber cell at a specific developmental and
differentiation stage, we have made use of an in vitro
differentiation system. In this system, the monolayer of epithelial
lens cells, still attached to the lens capsule, is cultured in the
presence of bFGF,1 which
induces the differentiation of lens epithelial cells to lens fiber
cells (Ref. 15; for review, see Ref. 16). The lens fiber cells follow
the course of differentiation also seen in vivo, including
the typical changes in morphology and the accumulation of the various
crystallins. The lens epithelial cells are aware of their developmental
age and differentiate to fiber cells corresponding to that
developmental age (17, 18). When explants are taken from newborn rats,
copious accumulation of -crystallin is seen after about 10 days of
in vitro culture (19-21). Lens explants isolated from older
rats differentiate more slowly in vitro than those from
younger rats and accumulate less -crystallin mRNA and protein
(18, 21); in differentiating explants from 10-day-old rats, the
-crystallin mRNA levels are only 1% of that seen in newborn
explants,2 and below the
level of detection in explants from 14-day-old rats (21).
In a previous study (7), we analyzed the course of activation of the
D-crystallin promoter during the in vitro differentiation of rat lens explants isolated from newborn rats. Demethylation of this
promoter occurs within the first 2 days of in vitro
differentiation, long before activation of the endogenous gene. The
pulse of activity of the endogenous gene, between days 10 and 12 (21),
was suggested to be regulated by the balance of activity of a
transactivating factor binding the -box, first detected around day
6, and of a silencing factor, which appears around day 10 (7). To
investigate developmental changes in these regulatory interactions, we
have now followed the activation of the D-crystallin promoter during in vitro differentiation of lens epithelial explants
isolated from 10-day-old rats. We show here that in explants from these older rats, promoter demethylation is delayed, whereas the silencing factor appears earlier. We have further compared the D-crystallin promoter with the B-crystallin promoter, the promoter with the most
extended developmental expression. We show that the -boxes of the
D- and B-crystallin promoters, which resemble a Maf recognition element (MARE; Refs. 22 and 23), are recognized by the same factor,
possibly a Maf protein, but that the affinity of the B-box for this
factor is much lower than that of the D-box. Activity of the
B-crystallin promoter requires interaction with an AP-1 binding site
directly downstream of the B-box. Like the D-crystallin promoter,
the expression of the B-crystallin promoter is subject to silencing,
but the silencing factor differs from the one that represses the
D-crystallin gene.
 |
EXPERIMENTAL PROCEDURES |
Cell Culture--
Lens epithelial explants from newborn or
10-day-old (as indicated) Wistar rats were obtained essentially as
described (24). Rat lenses were isolated in Medium 199 (Life
Technologies, Inc.). The lens capsule together with the anterior
monolayer of epithelial cells were peeled off the fiber cell mass and
pinned down on a 3.5-cm Petri dish. Explants (three per dish) were
cultured as described previously (7). Basic FGF (a kind gift from
Scios, Inc., Mountain View, CA) was added to a final concentration of 25 ng/ml, and the cells were cultured for the indicated period prior to
transfection.
Isolation of Chromosomal DNA and Ligation-mediated Polymerase
Chain Reaction (PCR)--
Isolation of chromosomal DNA from lens
explants and ligation-mediated PCR was performed as described
previously by Dirks et al. (7).
In Vitro Methylation of DNA--
CpG-methylation of DNA using
SssI methylase was essentially according to the
manufacturer's protocol (New England Biolabs). Total reaction time was
4 h, whereby addition of enzyme and S-adenosylmethionine to the
reaction mix was repeated after 2 h. Completeness of methylation was tested by a pilot digestion using ThaI and
electrophoresis through an agarose gel.
Mutagenesis and Reporter Gene Constructs--
The template for
mutagenesis was single-stranded DNA from a pBluescript II
(SK ) (Stratagene) construct containing the
D-crystallin 1087/+48 fragment. Oligonucleotides for mutations
were DB1 (5'-GCT GTT CCT GTC AAC GCA GC-3' at position 64/ 45), DB2
(5'-GTT CCT GTC AAG GCA GCA GAC-3' at position 61/ 41), and DB3
(5'-CTG TTC CTG TGG AGG CAG CAG-3' at position 63/ 43) to obtain the
mutants DB1, DB2, and DB3, respectively. Oligonucleotide DB4
(5'-GCA GCA GTC ATG ACA GCT ATA TAT ATA GAT C-3' at position 46/ 15) was used to mutate both the wild type D-crystallin promoter and the
mutant DB3 promoter to obtain D4 and DB4, respectively, and
oligonucleotide BD1 (5'-TGG AGG CAG CAG ACC TCC TGC TAT ATA TAC CAG-3'
at position 55/ 21) to obtain BD1. Mutations were introduced
using the Sculptor in vitro mutagenesis system version 3 (Amersham, UK). The BglII ( 375)/FokI (+10)
promoter fragment of each mutant was cloned into pEUCAT (25).
Subsequently, replacement of the D 10 region by its F
equivalent was performed by using the oligonucleotide DF (5'-TGT AGG
GCT GGG AGC AGG GTC TAT A-3'), representing the sequence at position
23 to +1 of the F promoter, and the oligonucleotide UMS (5'-TGC
ATT AAA TTC CAG GAA CTT GCT TTC TGT G-3'), priming upstream from the
pEUCAT multiple cloning site, in a PCR reaction using wild-type and
mutant D promoter constructs as templates. PCR products were cloned
into pEUCAT. All mutants were checked by dideoxy sequence analysis
(26). To delete the upstream region, promoter constructs were truncated at the 73 ApaI site. Other promoter constructs used have
been described previously (12).
D-Crystallin Silencer Promoter
Constructs--
Oligonucleotides DS1 s (5'-TCG AGT GCC CTG CCC CCC GCG
G-3') and DS1a (5'-TCG ACC GCG GGG GGC AGG GCA C-3') were annealed (27)
and cloned into the SalI site of pBLCAT2 (28) to obtain construct pBLCAT2 DS1. The ApaI ( 73)/BamHI
fragment of pBLCAT2 (8) was exchanged with that of pBLCAT2 DS1 to
obtain pBLCAT2 DS. The B- XhoI ( 414)/ApaI
( 73), C- NheI ( 183)/ApaI ( 69), D- PvuII ( 193)/ApaI ( 73), and F-crystallin
SpeI ( 280)/ApaI ( 70) blunt-ended/sticky
fragments were inserted into pBLCAT2 by replacement of its
HindIII (blunt)/ApaI fragment to obtain
pBLCAT2 B, pBLCAT2 C, pBLCAT2 D, and pBLCAT2 F, respectively.
Construct pBLCAT2 BS was obtained by deletion of the 414/ 110
fragment from pBLCAT2 B using the SacI site at position
10.
DNA Transfection, Chloramphenicol Acetyltransferase (CAT) Assay,
and -Galactosidase Assay--
Plasmid DNA was isolated according to
the alkali lysis procedure (27) in conjunction with either the Wizard
Maxiprep System (Promega) or CsCl gradient centrifugation (27). DNA was
transfected to the lens cells using either Lipofectamine Reagent (Life
Technologies, Inc.) or the PDS-1000/He Biolistic Particle Delivery
System (Bio-Rad). When cells were transfected using Lipofectamine, per
dish 2.0 µg of CAT reporter construct and 0.25 µg of CMV/ -gal
construct (29) were transfected to the cells according to the
manufacturer's protocol. Using the Biolistic Particle Delivery System,
0.5 µg of CAT reporter construct and 0.125 µg of CMV/ -gal
construct was coated on 1-µm gold particles and bombarded on the
cells at 450 psi helium. After culturing for 3 more days in the
presence of 25 ng/ml bFGF, the cells were harvested in 100 µl of
reporter lysis buffer (25 mM bicine, pH 7.8, 0.05% Tween
20, 0.05% Tween 80) per dish, and vigorously shaken for 10 min. The
cell debris was pelleted in an Eppendorf centrifuge. To determine
transfection efficiency, 20 µl of the supernatant was used to assay
for -galactosidase activity (29). The remainder of the supernatant
was heated for 15 min at 65 °C to inactivate cellular deacetylases.
From the supernatant, 20 µl was used to assay for CAT activity as
described by Gorman et al. (30) or using the Quan-T-CAT
system (Amersham). Transfections were done in duplo or triplo, and two
DNA isolates from each construct were tested in independent
experiments.
Electrophoresis Mobility Shift Assay (EMSA)--
Nuclear
extracts were prepared as described previously (12). EMSAs were
performed essentially as described (31, 32). DNA restriction fragments
were size-fractionated through a native 6% polyacrylamide gel and
isolated by electro-elution using a Bio-Trap apparatus (Schleiger and
Schuell), according to the manufacturer's protocol. Approximately
0.1-0.5 ng of end-labeled probe (10,000-20,000 cpm) was added to
5-10 µg of nuclear extract (5 µl, final concentration of 100 mM NaCl) and either 1.0 µg of poly(dGdC·dGdC) or
1.0-3.0 µg of poly(dIdC·dIdC), as indicated, in binding buffer
(final concentrations 20 mM HEPES, pH 7.9, 10-50
mM KCl as indicated, 1 mM EDTA, 1 mM DTT, 4% (v/v) Ficoll) in a total volume of 20 µl. The
reaction mixture was left for 10 min at room temperature, loaded on a
pre-run 4% (w/v) polyacrylamide gel in 0.25 × TBE (1 × TBE = 89 mM Tris-HCl, 89 mM boric acid,
2.5 mM EDTA), which then was run for 2 h at 10 volts/cm. The gel was dried and exposed to a Fuji AX film overnight
with one intensifying screen.
In Vitro Footprint Analysis--
The appropriate DNA fragment
was 32P-labeled at one end. An aliquot (600,000 cpm) was
methylated using dimethylsulfate (DMS) essentially as described (33,
34). The methylated probe was incubated with 150-200 µl of nuclear
extract (150-400 µg of protein) for a preparative gel retardation
assay (analytical assay 30-40-fold scaled up). The complexed and the
free probe were visualized by autoradiography overnight. The DNA was
cut out of the gel, isolated by electro-elution as described above,
cleaved by piperidine (final concentration 10% (v/v)), and
size-fractionated in a 15% sequencing gel. The gel was dried, and
exposed to a Fuji AX film for 18-72 h.
 |
RESULTS |
Demethylation of the D-Crystallin Promoter Region--
In
explants from newborn rats, the D promoter region is fully
demethylated between day 1 and 2 of in vitro differentiation (Ref. 7; see also Fig. 2A). To test whether promoter
demethylation still occurs in 10-day-old rat explants, in which the
level of expression of the D promoter is about 50-fold lower, the
state of methylation of the genomic ThaI site at position
13 of the D promoter was followed during in vitro
differentiation. In a parallel experiment, the methylation state of
this ThaI site in explants from newborn rats was tested. In
newborn rat explants, virtually complete demethylation of the
ThaI site was found after 2 days of culture, in agreement
with the results of Dirks et al. (7). In contrast,
demethylation of this site was significantly slower during
differentiation of explants from 10-day-old rats (Fig. 2A).
Even after 5 days of differentiation, demethylation was only 65%
complete.
To determine the effect of DNA methylation on D promoter activity, a
D( 73/+10)CAT fusion gene was methylated using CpG methylase and
transfected into explanted lens cells. We found a strongly reduced
activity of the methylated construct; activity was only 1% of that of
the unmethylated promoter and within background levels (Fig.
2B). Although the CAT coding region is also methylated in
these experiments, other studies have shown that DNA methylation does
not impede elongation (35-37) and that methylation of the CAT coding
sequence does not affect transient expression (6, 38). Hence, the
effect of CpG methylation is likely to block D promoter activity,
although from our own experiments, we cannot rule out an aspecific
effect.
The D promoter contains a CpG site in its proximal activator, the
-box, located around 50 (see also Fig.
1). To test whether methylation of the
-box element is sufficient to block binding of the cognate
activating factor in vitro, the binding of rat lens nuclear
extract factors to a methylated promoter fragment was compared with
that to a nonmethylated fragment in an EMSA. Complex formation with the
methylated fragment was reduced when compared with that of the
unmethylated fragment, but not abolished (complex D1; Fig.
2C). This was confirmed by the
fact that the methylated fragment competed for the activator complex as
efficiently as the unmethylated fragment itself. In the EMSAs using the
methylated D promoter fragment, an additional band is seen (complex
D2; note that this complex migrates slower than the faint aspecific complex seen in some of the other lanes). This band could represent binding to the methylated DNA by general MCpG binding
proteins.

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 1.
Sequence alignment of the 5'-flanking regions
of the six rat -crystallin genes. The sequence of the -box
region of the mouse F-crystallin promoter is shown for comparison.
Only the D sequence is shown in full; for the other sequences, only
differences are specified. Dashes indicate gaps introduced
to optimize alignment. The TATA-box is shown in bold.
Transcription start sites are indicated by arrows.
Asterisks mark residues involved in factor binding in lens
cells, as demonstrated by in vivo footprint analysis (7).
The activator element at position 57 to 46 of D-crystallin
promoter, the -box, is indicated as suggested by Peek et
al. (8) as is the silencer region. Note that the nucleotide
sequence of the mouse F-crystallin -box is identical to that of
the rat D-crystallin -box except for the A, which is present in
the rat A- and C-crystallin -box sequences as well. Also note
that the B-crystallin equivalent of the -box, and the region
directly downstream, contains the most nucleotide changes relative to
that of the D-crystallin, and that the E- and F-crystallin
promoters lack the G/C-rich 10 region present in the D-crystallin
promoter. Sequences and their alignment are according to Den Dunnen
et al. (9); the mouse F-crystallin promoter sequence is
from Lok et al. (10).
|
|

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 2.
Demethylation of the D-crystallin promoter
during development. A, analysis of the
methylation state of the genomic ThaI site at position 13.
Lens explants from both newborn and 10-day-old rats were cultured in
the presence of bFGF and harvested at several stages during
differentiation. Chromosomal DNA was isolated as described previously
(7) and digested with both ThaI (cuts at 13) and
Sau3A (cuts at 23). The DNA was amplified by
ligation-mediated PCR using three primers in succession (from +85/+67,
+42/+21, and +42/+19; for details see Ref. 7) and visualized by
electrophoresis and autoradiography. PCR products from methylated and
unmethylated DNA are indicated. Both the autoradiograph and the
quantitated data are shown. B, activity of methylated
(mutant) D- or C-crystallin promoters. Wild-type and mutant
73/+10 D-crystallin promoter constructs or the 70/+28 C
promoter construct were in vitro methylated using CpG
methylase (SssI methylase). Methylated and mock-methylated
constructs were transfected to explants pre-cultured for 10 days in the
presence of bFGF. The explants were cultured for three more days before
harvesting (see "Experimental Procedures" for details). Activities
of the non-methylated D and C promoter constructs were set at
100%; the activity of DB2 or DF is given relative to that of
D. The bars indicate the standard deviation.
C, factor binding to the CpG-methylated -box. Methylated
and unmethylated D ( 73/+45) fragments were used as probes, as
indicated. Completeness of DNA methylation was tested by digestion
(ThaI), and factor binding was examined in the absence ( )
and presence (+) of nuclear extract from newborn rat lenses. Binding was in the presence of 50 mM KCl and
50 ng/µl poly(dGdC·dGdC). Complex D1 represents the D-crystallin
activator complex ( -box complex), as confirmed by methylation
interference footprint analysis using the 73/+45 fragment (results
not shown). Complex D2 might represent binding of
MCpG-binding protein, as it is found only with the
methylated probe. Specific competitor DNA was added in a 100-fold molar
excess (right two lanes).
|
|
These data suggest that methylation of the -box is not sufficient to
suppress promoter activity. We therefore tested the effect of
methylation on the activity of mutant constructs, lacking either the
CpG site at 50 or the CpG sites between 20 and 10. The activity
of these mutant D promoters, when methylated, was also in the
background range (Fig. 2B). Similarly, the activity of the
C promoter was also very low when methylated. Together, our results
indicate that the reduction in -crystallin promoter activity by
methylation is a general effect and not due to methylation of a
specific site.
Appearance of Trans-acting Factors during in Vitro Lens Cell
Differentiation--
We have previously proposed that the
differentiation stage-specific expression of the D-crystallin gene
during fiber cell differentiation was regulated by the phased
appearance of first an activating and then a silencing factor (7). The
reduced activity of the D promoter in explants of 10-day-old rats
could be due to a changed expression profile of these factors.
Therefore, the activities of the D( 73/+45)CAT fusion gene and of a
silencer-tkCAT construct were followed during the course of
differentiation of 10-day-old explants. The D( 73/+45)CAT construct
was active at all stages of differentiation, with a maximum around day
12 (Fig. 3A). The timing of
up-regulation of the D activating factor in these explants is very
similar to that in explants from newborn rats (see Ref. 7). However,
the activity of the D( 73/+45)CAT construct in 10-day-old explants
was around 50% of that in explants from newborn animals (data not
shown), indicating that the level of the activating factor is decreased
in the older explants.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 3.
Activities of the proximal D-crystallin
promoter and its silencer element during differentiation of explants
from 10-day-old rats. Transfections were done as described under
"Experimental Procedures." The dotted lines represent
the activities obtained using newborn rat lens explants as reported
previously (7). A, activity of D( 73/+45)CAT transfected
into explants from 10-day-old rats at several stages of bFGF-directed
differentiation. Activities are shown relative to that of the maximum
level (100%). The bars indicate the standard deviation.
B, activity of pBLCAT2 (8), containing four copies of the
85/ 67 silencer region in front of the tk promoter, transfected to
explanted lens cells from 10-day-old rats at several stages of
differentiation. Activities are shown relative to that of the parental
construct pBLCAT2, which was set at 100% (not shown). The
bars indicate the standard deviation.
|
|
Rather different results were obtained when the presence of the
silencing factor was assayed for; the construct containing four copies
of the silencing element in front of the HSV tk promoter was inactive
even in early differentiated cells from 10-day-old rats (Fig.
3B), indicating that the silencing factor is present throughout differentiation of these cells. In contrast, in explants from newborn rats, silencing activity was maximal only after 10 days of
in vitro differentiation (Ref. 7; see also Fig.
5B). The level of silencing in fiber cells from 10-day-old
rats was not significantly different from that during late
differentiation of cells from newborn animals. The earlier appearance
of the silencing factor might well explain the reduced activity of the
D gene in the 10-day-old explants.
The D-Crystallin Silencing Factor--
The D silencer was
originally found by chance, when testing the effect of the 84/ 71
G/C-rich region conserved among the -crystallin promoters. This
region suppresses gene activity in non-lens cells such as retina, skin,
and brain (12). In vivo footprinting in lens cells, however,
showed that nuclear factor contacts extended further upstream to 88
(7). In view of its importance in the developmental shut down of the
D gene, we have reexamined this region. Methylation interference
footprinting showed a contacted region between 91 and 79 in the
upper strand and between 90 and 78 in the lower strand in both a
lens and a brain nuclear complex, suggesting the presence of the same
factor in lens and brain cells (Fig. 4,
A and B). This was further confirmed by
measurement of the molecular weight of the factors in an EMSA-based method (39), in which the mobility of the complexes in gels of
different polyacrylamide concentrations were compared. The molecular
masses of both the lens and brain complexes, including the
oligonucleotide probe, were estimated at 105 kDa (Fig. 4C). These results strongly suggest that the lens and brain factors are the
same and bind the D silencer element at position 91 to 78 in
both tissues. Apparently, this ubiquitous, or at least not
lens-restricted, factor has been recruited by the lens to function in
the differentiation and developmental control of the D-crystallin
promoter.

View larger version (50K):
[in this window]
[in a new window]
|
Fig. 4.
Nuclear factor from lens or brain binds the
D-crystallin silencer at the same site. A,
methylation interference footprint analysis of the D-crystallin 80
region complexed by either lens or brain nuclear factors.
D-crystallin 106/+45 promoter fragment (containing mutation
46G T, thus abolishing factor binding to the -box; see Ref. 7)
was 32P labeled at either end and used to bind nuclear
factors from either newborn rat lens or brain. Results using both free
(F) and bound (B) DNA are shown. Sites of protein contacts are
indicated by brackets. B, summary of
footprint analyses shown in A. Residues involved in factor
binding are specified by asterisks. Nucleotide sequence is
as reported by Den Dunnen et al. (9). C, estimate
of the molecular weights of gel-retarded DNA/protein complexes as
described by Orchard and May (39). A cloned 32P-labeled
oligonucleotide containing the 91/ 78 D-crystallin silencer
element ( DS1; see Fig. 5) was bound to either lens or brain nuclear
extracts. EMSAs were run together with native standard proteins in a
series of gels with increasing polyacrylamide concentration. The
relative migration of the DNA/protein complexes (B, complex brain; L,
complex lens) and standard proteins (BSA, bovine serum albumin; CA,
carbonic anhydrase) were plotted against the polyacrylamide
concentration (left). Rf is the migration distance relative
to the migration distance of bromphenol blue. The negative slopes of
the curves from the standard proteins were then plotted against their
molecular weights in a Ferguson plot (39), from which the molecular
weight of the lens and brain nuclear complexes was determined
(right).
|
|
A synthetic copy of the 91/ 78 element silenced the heterologous tk
promoter by about 65% (Fig.
5A; DS1), which
corresponded to the silencing activity of a larger promoter fragment
( D), whereas the conserved G/C-rich region ( 84/ 68; ) silenced
by about 25%. Thus, the 91/ 78 element is the silencer element
within the D promoter. The in vivo activity of the
original tetramer silencer construct (Ref. 7; see Fig. 3B),
although containing only part of the silencer element is probably due
to the fact that the multimerization of the 84/ 68 sequence by
chance partially provided the missing part of the element.

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 5.
The D-crystallin 91/ 78 promoter
element is a functional silencer in lens cells. Constructs
containing the D-crystallin promoter sequences fused to the tk
promoter as indicated in the figure were transfected to explants from
newborn rats precultured in the presence of bFGF for 11 days
(A) or as indicated (B). After 3 days, the cells
were harvested, and the CAT activities were determined as described
under "Experimental Procedures." CAT activities are shown relative
to that of pBLCAT2 (100%). The bars indicate the standard
deviation. The silencer sequence is underlined. Sequences
are according to Den Dunnen et al. (9).
|
|
The Common Proximal Activator of the -Crystallin
Promoters--
The alignment of the proximal promoters of the
-crystallin genes shows that the -box is a well conserved element
(Fig. 1) and predicts that all -crystallin promoters, with the
possible exception of the B promoter, bind the same factor. Indeed,
nuclear factor binding to the D promoter is efficiently competed for by the C and the F promoter (data not shown). The B promoter fragment, however, competed poorly for binding (Fig.
6A). As the B promoter is
also the one with the most extended developmental expression, we
analyzed the B promoter element in more detail.

View larger version (31K):
[in this window]
[in a new window]
|
Fig. 6.
The B-crystallin -box region.
A, EMSAs showing binding of the 32P-labeled
D-crystallin 73/+45 promoter fragment in lens nuclear extracts
(+), competed with the equivalent B-crystallin promoter fragment.
Binding was in the presence of 50 mM KCl and 50 ng/µl
poly(dGdC·dGdC). Specific competition DNA was added in a 10-200-fold
molar excess, as indicated. In the first lane ( ), no extract was
added. Only the region of the autoradiograph with bound probe is shown.
See "Experimental Procedures" for details. B, reciprocal
competitive EMSAs using the 32P-labeled B-crystallin
73/ 16 promoter fragment as a probe. See A for further
details. Note the appearance of an additional, specific complex (B2)
migrating faster then B1. C, in vitro
methylation interference footprints of the upper (coding) strand.
32P-labeled B-crystallin 73/ 16 fragment was
methylated and bound to nuclear factors from newborn rat lenses. See
"Experimental Procedures" for further details. Sequence ladders of
both bound (B) and free (F) probes are shown. Positions of the G
residues relative to the transcription start site are indicated. Sites
of protein contact are marked by brackets.
D, summary of the results shown in C. G
residues involved in protein interaction are marked by
asterisks. Binding sites in complexes B1 and B2 are
indicated. AP-1 consensus binding sites are specified by arrows. Nucleotide sequence and numbering are
according to Den Dunnen et al. (9).
|
|
A promoter fragment containing the B-box yielded two complexes in an
EMSA. The lower complex (B2) was competed for by the B but not by a
D fragment and thus appeared to be B-specific (Fig.
6B). The upper complex (B1) comigrated with the single
complex formed by the equivalent D promoter fragment (not shown) and was also competed for efficiently by this D fragment (Fig.
6B), suggesting that this complex represents the B
57/ 46 activator ( B-box) complex. Competition by the B
fragment for either the D-box (Fig. 6A) or the B-box
complex (Fig. 6B) was very poor, confirming the relatively
low affinity of this B promoter element for factor binding. To
confirm the conclusion that complex B1 (see Fig. 6B)
represents binding to the B 57/ 46 region, this complex was
mapped by in vitro footprinting. As shown in Fig. 6C (left panel), the B1 complex is indeed the
result of factor interaction between positions 55 and 46. In
vitro footprinting of complex B2 showed that the binding site in
this complex is the 46 to 38 region (Fig. 6C,
right panel), directly adjacent to the B-box. The B2
footprint corresponds to a consensus AP-1 site (Fig. 6D). A
second AP-1 site is located directly downstream, but no interaction
with this site was seen in vitro.
To understand the functional significance of the low affinity binding
by the B-box, the D-box was exchanged for the corresponding B
element. Mutating the D-box in the D( 375/+10)CAT construct successively to the equivalent B sequence led to a gradual decrease in promoter activity (Fig. 7A,
left panel), showing that the B-box is a lesser activator
than the D-box. The drop in activity is sharpest between mutant
constructs DB1 and DB2, nicely corresponding to the in
vitro binding affinity of these mutants; DB1 still efficiently
competes with the D sequence, but DB2 no longer does so (Fig.
7B). An even more dramatic effect of mutating the D-box
to the B-box is seen when the upstream region is deleted from the
375/+10 constructs (Fig. 7A, right panel).
Deletion to 73 in the wild-type D promoter has only a slight
effect on promoter activity. However, introducing two nucleotide
substitutions in the D-box ( DB2) now results in activity barely
above background. Hence, elements in the upstream region contribute to
promoter activity, but this effect is only seen experimentally when the -box sequence is less than optimal.

View larger version (31K):
[in this window]
[in a new window]
|
Fig. 7.
B-crystallin promoter elements.
A, functional comparison of the B- and D-boxes and
mutant intermediates. The -box sequence in a D( 375/+10)CAT
construct was successively mutated to its B equivalent yielding
constructs DB1 to DB3 (left panel). B-like
sequences are underlined. These constructs and a
B( 414/ 16)CAT construct were transfected into explanted lens
cells from newborn rats, following a preculture period of 10 days in
the presence of bFGF. Cells were cultured for three more days before
harvesting. Promoter activities were determined as described under
"Experimental Procedures." Similar experiments were performed with
constructs in which the upstream sequences were deleted to 73
(right panel). All activities shown are relative to that of
the parental D( 375/+10) promoter construct (100%). The
bars indicate the standard deviation. B, EMSA
showing binding of 32P-labeled wild-type D( 73/+10)
fragment and lens nuclear extract (+) competed with the D fragment,
the equivalent B fragment, or mutant fragments (see A).
Binding was in the presence of 50 mM KCl and 50 ng/µl
poly(dGdC·dGdC). Specific competitor DNA was used in 100-fold molar
excess. In the first lane, no extract was added ( ). Free (F) and
bound (B) probes are indicated. C, functional analysis
of the B 46/ 38 (B2) region. By in vitro mutagenesis,
the B 40 region was exchanged for its D counterpart yielding
construct BD1. The reciprocal experiment yielded construct D4.
Subsequently, the B-box was introduced in the latter construct,
yielding construct DB4. B-like sequences are
underlined. Arrows point to mutated nucleotides.
Constructs were transfected into explanted lens cells from newborn
rats, which had been precultured for 10 days in the presence of bFGF.
After three additional days of culture, the cells were harvested, and
promoter activities were assessed as described under "Experimental
Procedures." Activities are shown relative to the wild-type D
construct (100%). The bars indicate the standard
deviation.
|
|
The functional significance of the AP-1 consensus site at 46/ 38 in
the B promoter was tested by mutating this sequence to the
corresponding D sequence ( BD1; Fig. 7C). This mutation severely decreased promoter activity of the B promoter, showing that
the AP-1 site acts as an activator (Fig. 7C). This was
confirmed by the reciprocal construct, in which the 46/ 38 B
element was introduced at the corresponding site in the D promoter
( D4); again, this element functioned as an activator, as a 2-fold
increase in promoter activity was the result. Finally, we tested the
effect of a combination of both the B 57/ 46 and 46/ 38
elements in the D promoter. As expected, this construct ( DB4) had
the same low activity as the B-promoter itself.
The D-Box Is a MARE--
Kataoka et al. (22) first
suggested that the -box might be a Maf recognition element (MARE).
This suggestion is supported by the experiments reported by Ogino
et al. (40). We have therefore tested whether the factor
binding to the D-box also binds the MARE consensus sequence. As
shown in Fig. 8, in an EMSA using lens
nuclear extract, a D promoter fragment competes efficiently with
binding to a consensus MARE. In addition, the mobility of the D-box
complex is the same as that of a MARE complex (data not shown),
suggesting that the D-box does indeed bind a Maf, at least in
vitro.

View larger version (48K):
[in this window]
[in a new window]
|
Fig. 8.
The D-box resembles a MARE. EMSA
showing binding of a double-stranded MARE consensus oligonucleotide
(TGCTGACTCAG) and lens nuclear extract from newborn rats (+) competed
for with a D( 73/+10) fragment. As control, competition with the
MARE sequence is also shown. Binding was in the presence of 50 mM KCl and 50 ng/µl poly(dGdC·dGdC). Specific
competitor DNA was added in 10- and 100-fold molar excess. In the first
lane, no extract was added ( ). Free (F) and bound (B) probes are
indicated.
|
|
Two Maf sequences have been reported thus far to be present in the rat
lens, Maf-1 and Maf-2 (41, 42). Maf-2 is expressed in lens fibers but
not in epithelium, whereas Maf-1 is also present in epithelial cells.
Cotransfection of expression constructs for Maf-1 or Maf-2 and
D( 73/+10)CAT into differentiating lens explants showed that the
D promoter activity was stimulated about 2-fold by Maf-2 but not
Maf-1 (data not shown). Hence, the factor binding the D-box might
well belong to the Maf family.
The D 10 Element--
The data presented above show that the
B-box can function as an activator only in conjunction with the
downstream 46/ 38 element. Yet, the DB3 mutant, which lacks this
activator, still retains activity, albeit low (see Fig. 7A).
We therefore wondered whether an additional activating element is
present in the 73/+10 D promoter, which, in cooperation with the
low affinity DB3-box, drives promoter activity in this mutant.
Genomic footprinting of the rat D promoter had revealed a protected
site downstream of the TATA box: the GC-rich 10 region (Ref. 7; see
Fig. 1). The nucleotide sequence of this region is unique to the D
promoter and absent from the otherwise nearly identical E and
F promoters. To test the effect of the D 10 element, we
constructed D/ F promoter chimeras by replacing the D TATA box
and downstream region with the F equivalent, causing the mutations
21(T C), 18(C T), and 15 to 12(CGCG T ). The
latter series of four mutations is situated within the in
vivo footprint sequence mentioned above (see Fig. 1). In addition,
for practical reasons, the 5' noncoding sequence was truncated from +10
to +1.
The activity of the 375/+1 DF construct was not significantly
lower than that of the wild-type D construct when transfected into
explanted lens cells (Fig. 9). However,
shortening to 73 caused a drop in activity to about 20% of the
corresponding D construct. Introduction of the B-box in the
73/+1 DF promoter inactivated it, whereas mutation of the
G/C-region in construct D4 (see also Fig. 7C) strongly
decreased promoter activity. Hence, the D 10 region acts as an
activator. These data further show that the D-box is a relatively
poor activator and needs additional elements for full activity. In the
D promoter, such elements are located between 375 and 73 and
around 10. In the context of our experiments, these elements are
redundant. Finally, our results confirm the observation that the
B-box is inactive in the absence of other positive elements.
However, the positive element does not need to be positioned closely to
the B-box, as is the 46/ 38 element in the B promoter,
but can also be located at a distance, as is the 10 region in
the DB3 construct.

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 9.
The D-crystallin 10 region acts as an
activator. In the D-crystallin constructs indicated (see also
Fig. 7), the TATA box and downstream region were exchanged for the F
equivalent, and the 375/ 73 region was deleted. The D-box is
denoted by -box, in DB3 the D-box has been mutated to the
B-box sequence, B2 represents the AP-1 consensus sequence as found
in the B promoter. Constructs were transfected into newborn rat lens
explants, which had been precultured for 10 days in the presence of
bFGF. After three additional days of culture, the cells were harvested,
and promoter activities were assessed as described under
"Experimental Procedures." Activities are shown relative to the
wild-type D( 375/+10) construct (100%). The bars
indicate the standard deviation.
|
|
Differences between the B- and D-Crystallin
Silencers--
We have shown above that the -crystallin genes share
the -box activator. The question arises whether they all have
silencers, as predicted from the in vivo mRNA levels
(see Ref. 4) and, if so, whether these silencers are common or
specific. To examine the presence of silencer elements within the
-crystallin promoters, we determined the silencing activity of the
upstream regions of the -crystallin promoters (from position 69)
on the heterologous HSV tk promoter. All promoter regions tested
repressed activity of the tk promoter when transfected into explanted
lens cells, indicating that in all of these promoters, a functional
silencing element is present (not shown). Again the B sequence is
most divergent and was selected for further analysis.
The 414/ 69 B fragment, which showed silencing activity in
transient transfections, could be deleted to 110 without loss of
silencing activity in lens cells during terminal differentiation (not
shown), indicating that the B silencer element must be located between 110 and 69. To test whether the B and the D silencing regions bind the same or different factors, the mobility of the B
and D complexes was compared (Fig.
10A). Two B complexes
were found, both with mobility higher than that of the single D
complex, suggesting the formation of different B and D complexes.
The non-identity of the complexes was confirmed by competition assays; the D fragment did not compete for the B complexes nor did the B fragment compete for the D complex (Fig. 10A).

View larger version (32K):
[in this window]
[in a new window]
|
Fig. 10.
Comparison of the B- and D-crystallin
silencers. A, the B- and D-crystallin
silencer regions bind different factors in vitro.
32P-labeled fragments of the B- ( 110/-69, (BS) and
D-crystallin ( 93/ 76, DS1) promoters were incubated with rat
lens nuclear extract and electrophoresed through a native
polyacrylamide gel (+). Fragments were bound in the presence of 10 mM KCl and either 50 ng/µl poly(dGdC·dGdC) (in the case
of the B probe) or 50 ng/µl poly(dIdC·dIdC) (in the case of the
D probe). Specific competitor DNA was added in a 100-fold molar
excess. In the first and fifth lanes, no extract was added ( ). Free
(F) and bound (B) probes are indicated. See "Experimental
Procedures" for details. B, functional analysis of the
B-crystallin silencer region. The B( 414/ 69)-tkCAT and
B( 110/ 69)-tkCAT constructs were transfected to newborn rat lens
explants, precultured with bFGF for the time as indicated. The cells
were harvested 3 days later, and promoter activities were determined as
described under "Experimental Procedures." Activities are shown
relative to that of the tk promoter (pBLCAT2; 100%). The
bars indicate the standard deviation.
|
|
In ewborn explants, the D silencer is active only in terminally
differentiated fiber cells (Ref. 7; see also Fig. 5B). To determine whether the B silencer shows the same
differentiation-dependent expression, both the
B( 414/ 69)-tkCAT and B( 110/ 69)-tkCAT fusion genes were
transfected to in vitro differentiating lens fiber cells.
Like the D element, the B silencer demonstrated differentiation-dependent recognition, as silencing
activity was present only during a restricted period of differentiation
(Fig. 10B). However, this silencing activity was apparent
already between days 4-7 of differentiation and continued through the
terminal stage of differentiation. The 110/ 69 fragment demonstrated
silencing activity only during terminal differentiation, similar to the D silencer. Although the extent of silencing by the 110/ 69 fragment is similar to that of the larger 414/ 69 fragment during the course of differentiation, surprisingly, in early differentiation it strongly activated the tk promoter. Hence the 414 to 69 region of the B-crystallin gene must contain additional enhancers and silencing elements.
 |
DISCUSSION |
A simple mechanism for developmental regulation of the promoter
activity of the -crystallin genes would be that the level of
activity is determined by the affinity of a common activating factor
for the proximal activator, the -box. One would then predict that a
-crystallin promoter that is shut down early in development (e.g. E, F) would have a low affinity -box, whereas
a gene of which expression continues until later in development would have a high affinity -box. Our data clearly show that this
hypothesis is not correct; we find that the -crystallin gene with
the most sustained expression during development, the B gene, has
the -box with the lowest affinity.
Comparison of the B-box sequence with that of the D-box shows
that in the B-box the C at 54, which shows a protein contact in vivo (7), has been replaced by a T. This suggests that it is the 5'-half of the binding site in the B-box that is responsible for the low affinity. However, our results show that even such a
scrambled site is sufficient to target the corresponding cognate factors to the promoter, providing that additional activating elements
are present. The additional activating element can be either a closely
linked AP-1 site, as in the B promoter, or the more distant up- and
downstream elements of the D promoter. Hence, there is no constraint
on either the nature or the distance of the additional activating
element.
The -box resembles a MARE in sequence, and binding of a cognate
factor in lens extracts is competed by a consensus MARE sequence. Furthermore, the D promoter is slightly activated by cotransfection of an expression vector for Maf-2. Hence, the in vivo
activator of the -crystallin promoter might well belong to the Maf
family of transcription factors. Interaction of the mouse F-box with a (chicken) zinc finger protein has also been reported (11). However,
this protein acts as a transcriptional repressor rather than as an
activator.
The Maf family is a diverse one with small and large members (for
recent reviews, see Refs. 43-45). The large members, which include the
founding member of this family, v-Maf, have an N-terminal acidic
activation domain. The small members, such as MafF, MafG, and MafK,
lack this activation domain and can activate transcription only as
heterodimers with, for example, a large Maf member or a member of the
AP-1 family (e.g. see Refs. 22, 23, 45). Two large Maf
family members have thus far been shown to be present in the rat lens.
Maf-1 is the rat homologue of the mouse MafB, and Maf-2 may be the
homologue of the chicken c-Maf (41, 42). Maf-1 mRNA is primarily
found in the lens epithelial layer; Maf-2 mRNA is prominent in the
fiber cell mass, the site of expression of the -crystallin genes.
Expression of Maf-2 is not limited to the lens, since Maf-2, as well as
Maf-1, is also found in many other tissues of the body such as kidney,
spleen, and liver. Hence, a role for Maf-2 in the expression of the
-crystallin promoters is seemingly at odds with the lens specificity
of these promoters in transgenic mice (13, 14) or even in transgenic
Xenopus laevis (46). However, Maf-2 could partner
a lens-specific protein, and the role of Maf-2 in directing
lens-specific expression could be analogous to that of MafK in
erythroid-specific transcription; MafK acts as the partner of the
erythroid-specific transcription factor NF-E2 (47). Alternatively, the
"true" activator of the -crystallin promoters could be another
Maf protein. A possible candidate would be the rat homologue of L-Maf,
a lens-specific member of the Maf family found in the chicken lens
(40).3 However, it is not yet
known whether such a rat homologue indeed exists. Clearly, further
experiments are required to elucidate the role of Maf proteins in the
regulation of -crystallin gene expression.
AP-1 elements are targets of the Fos and Jun family of transcription
factors, well known for their role in transmitting growth factor
signals to the transcriptional apparatus. The involvement of an AP-1
element in the activity of the B promoter suggests that the activity
of this promoter is subject to regulation by extracellular factors.
This could play a role in the developmental regulation of the activity
of this gene and could further explain our rather puzzling observation
that the level of B mRNA reached during in vitro
differentiation is significantly lower than that found in
vivo.2 Apparently, bFGF is not capable of providing
the proper signals for maximal activation of the B promoter during
in vitro differentiation.
The -crystallin promoters contain an invariant sequence (CCCTTTTGTG)
located 35 base pairs upstream from the TATA box ( 73 to 63 in the
D promoter). The TTTG region in this sequence has been shown to be a
binding site for Sox-2, a member of the Sry family of transcription
factors (Ref. 48; see Fig. 11). The CCC are contacted by a factor in vivo, as they are detected on
the in vivo footprint of the D promoter (7). In that
paper, the assumption was made that these CCC formed part of the
silencer element. However, we show here that the silencer is located
further upstream and contacts the bases 90 to 78. The close
proximity of the CCC footprint at 73/ 71 to the Sox-2 target site
suggests that this footprint belongs to a factor that forms a
heterodimeric complex with Sox (note that Sox binds in the minor
groove, whereas in vivo DMS footprinting detects only major
groove G contacts). We have not studied the effect of this site on
-crystallin promoter activity here as the sequence is invariant. We
have previously shown that deletion of 77/ 71 in the F promoter
caused a 60% drop in activity (35).

View larger version (31K):
[in this window]
[in a new window]
|
Fig. 11.
Regulatory elements in the D- and
B-crystallin promoters. The transcription start sites are shown
by open arrows. The -box elements and surrounding
sequences are fully shown, whereas for the consensus binding sites of
known transcription factors only differences are indicated. Nucleotide
sequences and numbering are according to Den Dunnen et al.
(9). The nucleotide sequence of the -box elements resembles the
phorbol-12-O-tetradecanoate-13-acetate-responsive
element-type MARE (T-MARE; consensus sequence TGCTGACTCAG; see Refs. 44
and 45). Also, the consensus binding sequences of Sry/Sox-2 (48-50)
and AP-1 (e.g. Refs. 51 and 52) are shown.
|
|
Together, our studies show that there is a plethora of positive and
negative factor interactions in the proximal -crystallin promoter
(see Fig. 11). During development, the balance between these factors
shifts toward repression. At least for the D-crystallin promoter, it
is the developmental change in the pattern of expression of the
silencing factor that is the primary cause of promoter repression. Lack
of demethylation is probably a secondary cause. However, the rate of
promoter demethylation progressively decreases during development, and
at even later developmental stages the rate of promoter demethylation
may well be too slow to allow transcriptional activation, even if the
cognate transactivating factors are present. Note that demethylation of
the D promoter region cannot be passive, i.e. due to lack
of maintenance methylation following DNA replication, but must be
active as there is no cell division coincident with promoter
demethylation in differentiating lens explants.2 The
sequence elements that signal D promoter demethylation are unknown.
Mapping these elements has thus far been precluded by the low
transfection efficiency of lens explants at early stages of
differentiation. Our efforts are now directed at overcoming this
practical problem.
 |
ACKNOWLEDGEMENTS |
We thank Dr. M. Sakai for the kind gift of
the Maf-1 and Maf-2 expression constructs, and Lilian Hendriks and
Cécile Lesturgeon for excellent technical assistance.
 |
FOOTNOTES |
*
This work has been carried out under the auspices of the
Netherlands Foundation for Chemical Research and with financial aid from the Netherlands Organization for the Advancement of Pure Research
and the Dutch Diabetes Foundation.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Deceased.
To whom correspondence should be addressed. Tel.: 31-24-3652911;
Fax: 31-24-3652938; E-mail: nhl{at}sci.kun.nl.
1
The abbreviations used are: bFGF, basic
fibroblast growth factor; MARE, Maf recognition element; PCR,
polymerase chain reaction; CAT, chloramphenicol acetyltransferase; CMV,
cytomegalovirus; EMSA, electrophoretic mobility shift assay; tk,
thymidine kinase; HSV, herpes simplex virus.
2
E. J. Klok, S. T. van Genesen, A. Civil, J. G. G. Schoenmakers, and N. H. Lubsen,
unpublished results.
3
Yasuda, K., and Ogino, H. (1998) Science
280, 115-118
 |
REFERENCES |
-
Orkin, S. H.
(1995)
Eur. J. Biochem.
231,
271-281[Medline]
[Order article via Infotrieve]
-
Goring, D. R.,
Breitman, M. L.,
and Tsui, L.-C.
(1992)
Exp. Eye Res.
54,
785-795[CrossRef][Medline]
[Order article via Infotrieve]
-
Murer-Orlando, M.,
Paterson, R. C.,
Lok, S.,
Tsui, L.-C.,
and Breitman, M. L.
(1987)
Dev. Biol.
119,
260-267[CrossRef][Medline]
[Order article via Infotrieve]
-
van Leen, R. W.,
van Roozendaal, K. E. P.,
Lubsen, N. H.,
and Schoenmakers, J. G. G.
(1987)
Dev. Biol.
120,
457-464[CrossRef][Medline]
[Order article via Infotrieve]
-
Voorter, C. E. M.,
de Haard-Hoekman, W. A.,
Hermans, M. M. P.,
Bloemendal, H.,
and de Jong, W. W.
(1990)
Exp. Eye Res.
50,
429-437[CrossRef][Medline]
[Order article via Infotrieve]
-
Peek, R.,
Niessen, R. W. L. M.,
Schoenmakers, J. G. G.,
and Lubsen, N. H.
(1991)
Nucleic Acids Res.
19,
77-83[Abstract/Free Full Text]
-
Dirks, R. P. H.,
Klok, E. J.,
van Genesen, S. T.,
Schoenmakers, J. G. G.,
and Lubsen, N. H.
(1996)
Dev. Biol.
173,
14-25[CrossRef][Medline]
[Order article via Infotrieve]
-
Peek, R.,
van der Logt, P.,
Lubsen, N. H.,
and Schoenmakers, J. G. G.
(1990)
Nucleic Acids Res.
18,
1189-1197[Abstract/Free Full Text]
-
Den Dunnen, J. T.,
Moormann, R. J. M.,
Lubsen, N. H.,
and Schoenmakers, J. G. G.
(1986)
J. Mol. Biol.
189,
37-46[CrossRef][Medline]
[Order article via Infotrieve]
-
Lok, S.,
Breitman, M. L.,
Chepelinsky, A. B.,
Piatigorsky, J.,
Gold, R. J. M.,
and Tsui, L.-C.
(1985)
Mol. Cell. Biol.
9,
2221-2230
-
Liu, Q.,
Tini, M.,
Tsui, L.-C.,
and Breitman, M. L.
(1991)
Mol. Cell. Biol.
11,
1531-1537[Abstract/Free Full Text]
-
Peek, R.,
Kraft, H. J.,
Klok, E. J.,
Lubsen, N. H.,
and Schoenmakers, J. G. G.
(1992)
Nucleic Acids Res.
20,
4865-4871[Abstract/Free Full Text]
-
Goring, D. R.,
Bryce, D. M.,
Tsui, L.-C.,
Breitman, M. L.,
and Liu, Q.
(1993)
Dev. Dyn.
196,
143-152[Medline]
[Order article via Infotrieve]
-
Yu, C. C.-K.,
Tsui, L.-C.,
and Breitman, M. L.
(1990)
Development
110,
131-139[Abstract]
-
McAvoy, J. W.,
and Chamberlain, C. G.
(1989)
Development
107,
221-228[Abstract]
-
Chamberlain, C. G.,
and McAvoy, J. W.
(1997)
Progr. Retina Eye Res.
16,
443-478[CrossRef]
-
Lovicu, F. J.,
and McAvoy, J. W.
(1992)
Invest. Ophthalmol. Vis. Sci.
33,
2269-2278[Abstract/Free Full Text]
-
Richardson, N. A.,
and McAvoy, J. W.
(1990)
Exp. Eye Res.
50,
203-211[CrossRef][Medline]
[Order article via Infotrieve]
-
Lovicu, F. J.,
and McAvoy, J. W.
(1989)
Exp. Eye Res.
49,
479-494[CrossRef][Medline]
[Order article via Infotrieve]
-
McAvoy, J. W.,
and Richardson, N. A.
(1986)
Curr. Eye Res.
5,
711-715[Medline]
[Order article via Infotrieve]
-
Peek, R.,
McAvoy, J. W.,
Lubsen, N. H.,
and Schoenmakers, J. G. G.
(1992)
Dev. Biol.
152,
152-160[CrossRef][Medline]
[Order article via Infotrieve]
-
Kataoka, K.,
Noda, M.,
and Nishizawa, M.
(1994)
Mol. Cell. Biol.
14,
700-712[Abstract/Free Full Text]
-
Kerppola, T. K.,
and Curran, T.
(1994)
Oncogene
9,
675-684[Medline]
[Order article via Infotrieve]
-
Chamberlain, C. G.,
and McAvoy, J. W.
(1989)
Growth Factors
1,
125-134[Medline]
[Order article via Infotrieve]
-
Ammendola, R.,
Gounari, F.,
Piaggio, G.,
De Simone, V.,
and Cortese, R.
(1990)
Mol. Cell. Biol.
10,
387-390[Abstract/Free Full Text]
-
Sanger, F.,
Nicklen, S.,
and Coulson, A. R.
(1977)
Proc. Natl. Acad. Sci. U. S. A.
74,
5463-5467[Abstract/Free Full Text]
-
Sambrook, J.,
Fritsch, E. F.,
and Maniatis, T.
(1989)
Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
-
Luckow, B.,
and Schhtz, G.
(1987)
Nucleic Acids Res.
15,
5490[Free Full Text]
-
Jain, V. K.,
and Magrath, I. T.
(1991)
Anal. Biochem.
199,
119-124[CrossRef][Medline]
[Order article via Infotrieve]
-
Gorman, C.,
Moffat, L.,
and Howard, B. H.
(1982)
Mol. Cell. Biol.
2,
1044-1054[Abstract/Free Full Text]
-
Schreiber, E.,
Matthias, P.,
M
ller, M.,
Schaffner, W.
(1988)
EMBO J.
7,
4221-4229[Medline]
[Order article via Infotrieve] -
Schreiber, E.,
Matthias, P.,
M
ller, M.,
Schaffner, W.
(1989)
Nucleic Acids Res.
17,
6419[Free Full Text] -
Siebenlist, U.,
and Gilbert, W.
(1980)
Proc. Natl. Acad. Sci. U. S. A.
77,
122-126[Abstract/Free Full Text]
-
Tullius, T. D.
(1989)
Annu. Rev. Biophys. Biophys. Chem.
18,
213-237[CrossRef][Medline]
[Order article via Infotrieve]
-
Ben-Hattar, J.,
and Jiricny, J.
(1988)
Gene (Amst.)
65,
219-227[CrossRef][Medline]
[Order article via Infotrieve]
-
Keshet, I.,
Yisraeli, J.,
and Cedar, H.
(1985)
Proc. Natl. Acad. Sci. U. S. A.
82,
2560-2564[Abstract/Free Full Text]
-
Yisraeli, J.,
Frank, D.,
Razin, A.,
and Cedar, H.
(1988)
Proc. Natl. Acad. Sci. U. S. A.
85,
4638-4642[Abstract/Free Full Text]
-
Kruczek, I.,
and Doerfler, W.
(1983)
Proc. Natl. Acad. Sci. U. S. A.
80,
7586-7590[Abstract/Free Full Text]
-
Orchard, K.,
and May, G. E.
(1993)
Nucleic Acids Res.
21,
3335-3336[Free Full Text]
-
Ogino, H.,
Ishibashi, S.,
and Yasuda, K.
(1996)
Exp. Eye Res.
62,
226
-
Sakai, M.,
Imaki, J.,
Yoshida, K.,
Ogata, A.,
Matsushima-Hibiya, Y.,
Kuboki, Y.,
Nishizawa, M.,
and Nishi, S.
(1997)
Oncogene
14,
745-750[CrossRef][Medline]
[Order article via Infotrieve]
-
Yoshida, K.,
Imaki, J.,
Koyama, Y.,
Harada, T.,
Shinmei, Y.,
Oishi, C.,
Matsushima-Hibiya, A.,
Matsuda, Y.,
Nishi, S.,
Matsuda, H.,
and Sakai, M.
(1997)
Invest. Ophthalmol. Vis. Sci.
38,
2679-2683[Abstract/Free Full Text]
-
Blank, V.,
and Andrews, N. C.
(1997)
Trends Biochem. Sci.
22,
437-441[CrossRef][Medline]
[Order article via Infotrieve]
-
Motohashi, H.,
Shavit, J. A.,
Igarashi, K.,
Yamamoto, M.,
and Engel, J. D.
(1997)
Nucleic Acids Res.
25,
2953-2959[Abstract/Free Full Text]
-
Kataoka, K.,
Noda, M.,
and Nishizawa, M.
(1996)
Oncogene
12,
53-62[Medline]
[Order article via Infotrieve]
-
Brakenhoff, R. H.,
Ruuls, R. C.,
Jacobs, E. H.,
Schoenmakers, J. G.,
and Lubsen, N. H.
(1991)
Nucleic Acids Res.
19,
1279-1284[Abstract/Free Full Text]
-
Igarashi, K.,
Itoh, K.,
Hayashi, N.,
Nishizawa, M.,
and Yamamoto, M.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
7445-7449[Abstract/Free Full Text]
-
Kamachi, Y.,
Sockanathan, S.,
Liu, Q.,
Breitman, M.,
Lovell-Badge, R.,
and Kondoh, H.
(1995)
EMBO J.
14,
3510-3519[Medline]
[Order article via Infotrieve]
-
Collignon, J.,
Sockanathan, S.,
Hacker, A.,
Cohen-Tannoudji, M.,
Norris, D.,
Rastan, S.,
Stevanovic, M.,
Goodfellow, P. N.,
and Lovell-Badge, R.
(1996)
Development
122,
509-520[Abstract]
-
Denny, P.,
Swift, S.,
Connor, F.,
and Ashworth, A.
(1992)
EMBO J.
11,
3705-3712[Medline]
[Order article via Infotrieve]
-
Angel, P.,
Imagawa, M.,
Chiu, R.,
Stein, B.,
Imbra, R. J.,
Rahmsdorf, H. J.,
Jonat, C.,
Herrlich, P.,
and Karin, M.
(1987)
Cell
49,
729-739[CrossRef][Medline]
[Order article via Infotrieve]
-
Lee, W.,
Haslinger, A.,
Karin, M.,
and Tjian, R.
(1987)
Nature
325,
368-372[CrossRef][Medline]
[Order article via Infotrieve]
Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
T. Yamamoto, M. Kyo, T. Kamiya, T. Tanaka, J. D. Engel, H. Motohashi, and M. Yamamoto
Predictive base substitution rules that determine the binding and transcriptional specificity of Maf recognition elements
Genes Cells,
June 1, 2006;
11(6):
575 - 591.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. R. Weston, A. Wong, J. P. Hall, M. E.P. Goad, R. A. Flavell, and R. J. Davis
JNK initiates a cytokine cascade that causes Pax2 expression and closure of the optic fissure
Genes & Dev.,
May 15, 2003;
17(10):
1271 - 1280.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Civil, S. T. van Genesen, and N. H. Lubsen
c-Maf, the {gamma}D-crystallin Maf-responsive element and growth factor regulation
Nucleic Acids Res.,
February 15, 2002;
30(4):
975 - 982.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Carosa, Z. Kozmik, J. E. Rall, and J. Piatigorsky
Structure and Expression of the Scallop Omega -Crystallin Gene. EVIDENCE FOR CONVERGENT EVOLUTION OF PROMOTER SEQUENCES
J. Biol. Chem.,
January 4, 2002;
277(1):
656 - 664.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. G. Ilagan, A. Cvekl, M. Kantorow, J. Piatigorsky, and C. M. Sax
Regulation of alpha A-crystallin Gene Expression. LENS SPECIFICITY ACHIEVED THROUGH THE DIFFERENTIAL PLACEMENT OF SIMILAR TRANSCRIPTIONAL CONTROL ELEMENTS IN MOUSE AND CHICKEN
J. Biol. Chem.,
July 9, 1999;
274(28):
19973 - 19978.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|